Sort
38,696 grants matching “als”
Long-Term Nicotine Treatment of Mild Cognitive Impairment
$1,797,366Paul A. Newhouse · Vanderbilt University Medical Center · R01 · FY2018 · AG
Natural Products Discovery and Characterization Through Network Collaborations
$1,795,568Lin Du · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Regulation and impact of shortened TDP43 isoforms in FTD and ALS
$1,794,354Sami Barmada · University Of Michigan At Ann Arbor · R37 · FY2025 · NS
Lung Connective Tissue-Responses to Injury And Repair
$1,793,564Boston University Medical Campus · P01 · FY2003 · HL
AGING BRAIN: VASCULATURE, ISCHEMIA, AND BEHAVIOR
$1,792,500University Of Southern California · P01 · FY2001 · AG
Southeast Center for Agricultural Health and Injury Prevention
$1,792,078Wayne T. Sanderson · University Of Kentucky · U54 · FY2025 · OH
Regulatory and epigenetic landscapes in biological discovery, diagnostics and disease mechanisms
$1,792,057Laura L Elnitski · National Human Genome Research Institute · ZIA · FY2018 · HG
Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation
$1,791,773Munira Basrai · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Subunit-Specific Regulation Of Glutamate Receptors
$1,791,355Katherine Roche · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
MENTAL DISORDERS AS RISK FACTORS FOR SUBSTANCE DISORDERS
$1,790,695Harvard University (Medical School) · R01 · FY2002 · DA
Metabolic Control Analysis
$1,790,340Richard L Veech · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2018 · AA
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$1,790,298Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Structural characterization of OM proteins from Gram-negative pathogens
$1,790,153Susan Buchanan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Combination immunotherapy with gene modified CD4 and CD8 T cells and stem cells
$1,787,333Carl H. June · University Of Pennsylvania · U19 · FY2011 · AI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,786,679Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2009 · CA
Ubiquitin-dependent cell-fate decisions during human development and disease
$1,785,483Achim Werner · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE
Deubiquitinase USP19 in TDP-43 pathogenesis.
$1,785,220David E Kang · Case Western Reserve University · RF1 · FY2022 · NS
Disease mechanism and therapies for retinal degeneration
$1,785,213Tiansen Li · National Eye Institute · ZIA · FY2017 · EY
Drug Metabolizing Enzymes In Humans And Animal Models
$1,785,029Joyce Goldstein · Environmental Health Sciences · Z01 · FY2007 · ES
Transcriptional Control of Cell Specification and Differentiation During Zebrafish Development
$1,784,755Jeffrey Farrell · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Chemical Biology Platforms to Define the Metabolism-Epigenetics Interface
$1,784,658Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Cytidine modifications in mRNA processing and function
$1,784,337Shalini Oberdoerffer · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Blood-Brain Barrier Permeable Multimodal Imaging Agents for Neurodegenerative Diseases
$1,783,700Liviu M Mirica · University Of Illinois At Urbana-Champaign · RF1 · FY2023 · AG
Discovery And Functional Genomics Of Environmental Response Genes
$1,780,375Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
Potassium Channels and Dendritic Function in Hippocampal Pyramidal Neurons
$1,780,267Dax A Hoffman · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD